Skip to content
Technology Innovation

OMRON Releases the “Medium-Term Roadmap SF 2nd Stage”

OMRON Corporation 2 mins read
KYOTO, Japan--BUSINESS WIRE--

OMRON (TOKYO: 6645) has announced its “Medium-Term Roadmap Shaping the Future 2nd Stage (“SF 2nd Stage”),” covering from FY2026 to FY2030, on November 7, 2025 (JST). This Roadmap presents the Group’s vision and growth strategies through 2030, which are disclosed on our corporate website.

Overview of the “Medium-Term Roadmap SF 2nd Stage”

Since April 2024, OMRON has been implementing a Structural Reform Program “NEXT 2025” aimed at rebuilding our foundation for profitability and growth. With the completion of this Program in September 2025, we have shifted into a growth phase and formulated a new Roadmap looking ahead to 2030.

This Roadmap identifies Business Portfolio Restructuring as a core strategy. We have defined Thirteen Focus Businesses to drive the Group’s future growth. By accelerating our selection and concentration efforts, we aim to build a “distinctive” business portfolio that maximizes overall Group growth. Furthermore, to maximize the growth potential of our Focus Businesses, we will drive transformation decisively across three areas, “VALUE”, “FRONT”, and “Resource Allocation.”

Building on the profit foundation established through Structural Reform Program, we will thoroughly enhance our business growth capabilities and aim to increase corporate value through sustainable, profit-driven growth.

Related Information

Medium-Term Roadmap SF 2nd Stage

About OMRON

OMRON Corporation, as a leading automation company centered on its unique “Sensing & Control + Think” technology, develops businesses in Factory Automation, Healthcare, Social systems, Device and module, and Data solutions that utilize a wide variety of data acquired through these businesses. Founded in 1933, OMRON now employs about 27,000 people worldwide, provides products and services in more than 130 countries, and contributes to the creation of a better society.
Please visit the OMRON website for additional information.


Contact details:

Investor Relations Department
OMRON Corporation
E-Mail: [email protected]

Media

More from this category

  • Technology Innovation
  • 01/04/2026
  • 12:11
NIQ Global Intelligence plc

Global Beauty Market Grows 10% as AI and E-commerce Reshape Consumer Buying

Online sales outpace in-store by 6x as digital-first and AI-influenced commerce accelerates globally CHICAGO–BUSINESS WIRE– NielsenIQ (NYSE:NIQ), a global leader in consumer intelligence, today…

  • Contains:
  • Technology Innovation
  • 01/04/2026
  • 04:10
TestMu AI

bet365 Partners with TestMu AI to Accelerate Global Release Velocity with Agentic AI Quality Engineering

Streamlines Hillside Technology testing across browsers and mobile devices while supporting rapid expansion into regulated markets. SAN FRANCISCO & NOIDA, India–BUSINESS WIRE– TestMu AI…

  • Contains:
  • Technology Innovation
  • 01/04/2026
  • 00:40
Andersen Consulting

Andersen Consulting Strengthens Capabilities with Addition of Lukkap

SAN FRANCISCO--BUSINESS WIRE-- Andersen Consulting adds collaborating firm Lukkap, a consultancy focused on experience-driven capabilities aligned with clients’ evolving people, customer, and digital transformation needs. Founded in 2009 and headquartered in Spain, Lukkap delivers integrated solutions that help organizations transform how they serve customers, engage employees, and unlock value through behavioral insights and data analytics. The firm’s multidisciplinary approach spans customer journey redesign, high-impact employee experience programs, talent and leadership development, predictive analytics, and comprehensive outplacement and transition services. Lukkap works across sectors — including healthcare, pharmaceutical, consumer goods, retail, finance, and banking — to build human-centered strategies that drive…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.